Printer Friendly

Mark McClellan, Head of Centers for Medicare and Medicaid Services (CMS), to Give Update on Medicare Part D at MCPHS Conference.

BOSTON -- Massachusetts College of Pharmacy and Health Sciences has announced that Mark McClellan, Administrator for the Centers for Medicare and Medicaid Services (CMS), will deliver a keynote speech on the progress of Medicare D at the College's 66th Annual Howard L. Reed Conference. The event will be held on March 9, 2006 at Gillette Stadium in Foxboro, Mass.

Over 700 pharmacists from throughout New England are expected to attend the all-day Conference, which will also include seminars on the future of community pharmacy, an update on pharmacy law, and clinical presentations covering a variety of topics.

A physician and award-winning healthcare economist, Dr. McClellan has led CMS in its rollout of the historic Medicare Part D drug benefit, which began January 1, 2006. His presentation, "Medicare D: The First 60 Days", will chronicle the implementation of Medicare D, and the vital role pharmacists play in the success of the program.

"The Reed", as it is known, honors Dr. Reed for a lifetime of dedication and service to the College and bears his name in recognition of his role in conceiving the program in 1941. It was established as an opportunity for pharmacists to keep abreast of changes in the profession and for alumni to visit their former teachers and new faculty.

Founded in 1823, Massachusetts College of Pharmacy and Health Sciences is a private coeducational college offering graduate, professional and undergraduate degrees in pharmacy and health sciences. With campuses in Boston and Worcester, Massachusetts and Manchester, New Hampshire, MCPHS is the oldest institution of higher education in the City of Boston and its pharmacy program is the second oldest in the U.S. Professional or undergraduate degrees are offered in pharmacy, nursing, physician assistant studies, dental hygiene, radiologic sciences, environmental science, health psychology, chemistry, and premedical and health studies. Graduate programs are offered in drug regulatory affairs/health policy, drug discovery and development, pharmacy systems administration, pharmaceutical sciences, medicinal chemistry, and pharmacology. The College enrolls approximately 2,800 students, who are drawn from 32 states and 30 foreign countries, and employs more than 300 faculty and staff.

DAY OF EVENT PRESS CONTACT: Michael R. Ratty, Director of Communications, 617-877-7356 (CELL)
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 3, 2006
Words:360
Previous Article:Channel One Highlights Newsmakers for the Week of February 27, 2006.
Next Article:AOL Offers Full Email Functionality at No Charge to Any Qualified Not-for-Profit Organization.
Topics:


Related Articles
Subrogation traps for vulnerable plaintiffs: a plaintiff who has received a damages award may be forced to repay government benefits. Here's how to...
Congresswoman urges repeal of 'flawed' medicare drug card law.
Medicare Part D: omissions that affect SNFs.
Scully shares industry insights changes on the horizon.
FY'06 Medicare payments to LTCs could rise 3.1%.
Making sense of Medicare set-asides: as Medicare's role in workers' compensation and liability settlements evolves, a lack of clear guidance has left...
Procrastinators get dose of Part D.
CMS's new leader.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters